Significance Statement {#s1}
======================

The Cl^--^ concentration in central neurons is critical to normal synaptic function and if not properly regulated may contribute to epilepsy, chronic pain, and other pathologies. Here, we introduce a novel method to quantify the resting Cl^--^ conductance of the neuronal membrane and show how this conductance contributes to the recovery of Cl^--^ concentration after a high Cl^--^ load. We also clarify that ion channels of the GABA~A~ receptor type underlie a major fraction of the resting Cl^--^ conductance and show that an endogenous neurosteroid may quicken recovery of Cl^--^ concentration via effects of spontaneously released neurotransmitter on the GABA~A~ receptors. The findings are important for understanding the neuronal Cl^--^ homeostasis, critical to normal brain function.

Introduction {#s2}
============

The intraneuronal Cl^--^ concentration, \[Cl^--^\]~i~, is critical for synaptic communication. The inhibitory actions of GABA and glycine depend on a relatively low \[Cl^--^\]~i~. \[Cl^--^\]~i~ may, however, rise as a consequence of intense synaptic activity. When excitatory inputs depolarize the membrane, the driving force for inward Cl^--^ flux through channels opened by GABA or glycine increases and may impose a strong Cl^--^ load on the neuron. Cl^--^ flows into the cell also during shunting inhibition ([@B19]). In some cases, the raised \[Cl^--^\]~i~ changes the effect of GABA to excitatory ([@B40]; [@B3]). Restoring \[Cl^--^\]~i~ after large perturbations may thus be expected crucial for normal inhibitory GABAergic synaptic function. The K^+^-Cl^--^ cotransporter 2 (KCC2) is critical for the control of \[Cl^--^\]~i~ and likely contributes significantly to \[Cl^--^\]~i~ restoration ([@B19]). However, as a consequence of the negative resting potential maintained by neurons, passive Cl^--^ flux through Cl^--^ conducting membrane pathways may also contribute to the recovery of a low \[Cl^--^\]~i~. In the absence of Cl^--^ transporters, the Cl^--^ equilibrium potential (*E*~Cl~) will settle at the membrane resting potential. The relative importance of KCC2 and passive, "conductive" flux is at present unknown.

Conductive \[Cl^--^\]~i~ recovery depends on the resting membrane Cl^--^ conductance (*g*~Cl~). There is, however, no generally accepted view on the resting Cl^--^ permeability or *g*~Cl~ in central neurons. A low resting permeability has been suggested by [@B65], but a significant conductance has been described in other studies ([@B22]; [@B56]; [@B46]).

The molecular basis for resting *g*~Cl~ is also not well understood. It has been proposed that ClC-2 channels are general contributors to the resting *g*~Cl~ in neurons ([@B52]; but see [@B62]). However, the expression of ClC-2 is highly restricted to specific neuronal types ([@B60]) or neuronal compartments ([@B23]). Another contribution to resting *g*~Cl~ may be provided by GABA~A~ receptors, which underlie a tonic conductance in some neurons ([@B58]; [@B5]).

It seems possible that also the spontaneous GABA release that is seen as miniature postsynaptic potentials/currents (minis) contributes significantly to resting *g*~Cl~. The functional role of such minis is not clear. Although they imply relatively small currents, we hypothesized that they may be important for conductive recovery of \[Cl^--^\]~i~ after perturbations, at least when prolonged by endogenous neurosteroids that target GABA~A~ receptors and in some conditions also enhance GABA release ([@B27]).

In the present work, we estimated the contribution of passive Cl^--^ flux to \[Cl^--^\]~i~ recovery, in preoptic neurons from rat. We also developed a novel method to estimate the relative *g*~Cl~ at rest and analyzed whether ClC-2 channels and GABA~A~ receptors contribute to resting *g*~Cl~. Finally, we tested the hypothesis that spontaneous GABA release is important for \[Cl^--^\]~i~ recovery. To improve the electrical recording conditions and to avoid possible \[Cl^--^\]~i~ redistribution between neuronal compartments, we used acutely isolated neurons from which neurites were largely removed, but which retain attached presynaptic nerve terminals that enable analysis of spontaneous GABA release ([@B28]). Cells were loaded with Cl^--^ by combining GABA or glycine application with a depolarized voltage and \[Cl^--^\]~i~ was obtained from measurements of *E*~Cl~ by gramicidin-perforated patch recordings with GABA or glycine application in combination with voltage ramps ([@B38]; [@B72]).

Here, we show that passive Cl^--^ flux contributes significantly to \[Cl^--^\]~i~ recovery after a high load, and, using our novel method, we also show that Cl^--^ conductance accounts for ∼6% of the total resting conductance. A major fraction of this resting Cl^--^ conductance is picrotoxin (PTX)-sensitive and thus likely due to GABA~A~ receptors. Further, we show that when the decay of GABA~A~ receptor-mediated minis is slowed by the neurosteroid allopregnanolone, such minis contribute significantly to \[Cl^--^\]~i~ recovery, thus suggesting a possible steroid-regulated role for minis in the control of Cl^--^ homeostasis.

Materials and Methods {#s3}
=====================

Ethical approval {#s3A}
----------------

All animal procedures were performed in accordance with the regulations of the regional ethics committee for animal research (Umeå djurförsöksetiska nämnd, approval number A9-14).

Preparation of neurons {#s3B}
----------------------

Acutely dissociated neurons were prepared from in total 148 young, male Sprague Dawley rats, 50-110 g, three to five weeks of age ([@B39]). The animals were housed with *ad libitum* access to food and water under a 12/12 h light/dark cycle. They were killed by decapitation without anesthetics, the brain removed, and 200- to 300-μm-thick coronal slices containing the medial preoptic area were cut. Individual neurons were isolated by application of a vibrating glass rod just above the slice, at the location of the medial preoptic nucleus. The major parts of neurites were thus removed, but functional presynaptic terminals remained attached to the postsynaptic cell bodies ([@B28]).

Solutions used for preparation and for recording {#s3C}
------------------------------------------------

A solution of the following composition was used to cut and incubate brain slices and for mechanical dissociation of individual neurons: 150 mM NaCl, 5.0 mM KCl, 2.0 mM CaCl~2~, 1.2 mM MgCl~2~, 10 mM HEPES, 10 mM glucose, and 4.93 mM Tris-base, pH 7.4 (95% O~2~, 5% CO~2~). The extracellular solution used for recording contained: 137 mM NaCl, 5.0 mM KCl, 1.0 mM CaCl~2~, 1.2 mM MgCl~2~, 10 mM HEPES, and 10 mM glucose, pH 7.4 (NaOH). The standard pipette-filling solution contained: 140 mM K-gluconate, 3.0 mM NaCl, 1.2 mM MgCl~2~, 10 mM HEPES, and 1.0 mM EGTA, pH 7.2 (KOH). Gramicidin (Sigma-Aldrich) was prepared from a stock solution (120 mg/1.0 ml DMSO) to a final concentration of 600 µg/ml of pipette-filling solution. Alternatively, amphotericin B was prepared from a stock solution (6 mg/100 µl DMSO) and added to a final concentration of 120 µg/ml of pipette-filling solution. Pipette tips were filled with a similar solution without gramicidin or amphotericin B. Cells were continuously (between test applications of agonists) perfused with gravity-fed extracellular solution provided by a custom-made pipette positioned 100-200 µm from the studied cell. Computer-controlled exchange to solutions containing agonist via solenoid valves occurred with a time constant of ∼50 ms, as measured by the change in offset potential on changing between high and low K^+^ concentrations in the perfusate ([@B38]).

Electrophysiological recording {#s3D}
------------------------------

Electrophysiological experiments to study \[Cl^--^\]~i~ recovery were made by using the gramicidin-perforated patch technique, which enables recording of whole-cell currents without interference with the intracellular Cl^--^ concentration ([@B1]; [@B42]) and without current rundown ([@B70]). Experiments to estimate resting Cl^--^ conductance, which depend on estimates of \[Cl^--^\]~i~ but are compatible with slow Cl^--^ equilibration with the patch pipette, were made using the quicker amphotericin B-perforated patch technique ([@B51]). Both perforated-patch techniques are compatible with rapid Cl^--^ loading ([@B38]). The majority of experiments were made under voltage-clamp conditions, but a few control experiments were made under current-clamp conditions at zero current. Patch pipettes had a resistance of 3-4 MΩ when filled with standard pipette-filling solution and immersed in the standard extracellular solution (see above). Series resistance was evaluated repeatedly during experiments, by the "membrane test" provided in the Clampex software (versions 9 and 10; Molecular Devices), and was typically 15-40 MΩ. Online series-resistance compensation, which can never be complete and is associated with extra noise, was not used. For more complete compensation, all voltages were corrected for series resistance offline with voltage error computed from raw current and series resistance. Liquid‐junction potentials were calculated using the Clampex software and have been subtracted in all potentials given. All experiments were performed at room temperature (21-23°C).

Loading cells with Cl^--^ and estimation of \[Cl^--^\]~i~ recovery time course {#s3E}
------------------------------------------------------------------------------

Cells were loaded with Cl^--^, to concentrations up to ∼70 mM, by using combined depolarization and application of GABA (1.0 mM) or glycine (1.0 mM; [@B38]). Estimates of \[Cl^--^\]~i~ during loading as well as during recovery after loading were calculated from *E*~Cl~ as obtained from *I*-*V* relations constructed from rapid voltage ramps (rate of ± 1.6 V s^−1^) during brief applications of GABA or glycine (100 µM to 1.0 mM) and after correction for series resistance and subtraction of leak currents. The studied cells generated stable (for \>10 min) responses to GABA as well as to glycine during perforated-patch recordings ([@B20]). Since the method used to estimate \[Cl^--^\]~i~ depends on the current reversal potential, it is not sensitive to changes in the absolute GABA- or glycine-evoked conductance or peak current. Under the conditions used, without HCO~3~ ^--^ in the solutions, the reversal potentials for currents evoked by GABA or glycine (*E*~GABA~ and *E*~glycine~) are equivalent to *E*~Cl~ ([@B14]). The probe applications of GABA/glycine were given at a voltage close to the estimated *E*~Cl~ to minimize influence on \[Cl^--^\]~i~. The charge transfer associated with a probe application of GABA/glycine was estimated to affect \[Cl^--^\]~i~ by \<1.0 mM, as calculated from the "equivalent volume" of cytosol. The equivalent volume, v~equ~, was obtained from the Cl^--^ loading procedure and represented the volume in which the recorded charge transfer, Q, would cause the observed \[Cl^--^\]~i~ changes, Δ\[Cl^--^\]~i~, according to the relation: v~equ~ = QF^−1^ (Δ\[Cl^--^\]~i~)^−1^, where F is the Faraday constant. Thus, v~equ~ corresponds to the expected cytosolic volume ([@B38]). Leak currents, including small voltage-dependent components, were obtained from voltage-ramps given in the absence of GABA and glycine. The obtained leak *I*-*V* relation (after correction for series resistance) was fitted by a linear function or by the exponential function *I* = A + B *e^V^* ^/C^ (A, B, and C being constants). The latter function was used to calculate the leak current component when GABA or glycine was present. This procedure takes the differences in voltage, arising as a consequence of the series resistance and different current amplitudes, during ramps with and without GABA/glycine into account, and, therefore, provides a better estimate of leak currents than the commonly used technique to directly subtract the current recorded in the absence of ligand from that recorded in the presence of ligand. The similar results obtained with GABA and with glycine to load cells with Cl^--^ ([@B38]) show that the method used for loading is not critically influencing the results. Thus, GABA and glycine were here used interchangeably and each agonist was used for estimation of \[Cl^--^\]~i~ while blocking receptors for the other to clarify their role in \[Cl^--^\]~i~ regulation.

Derivation of relative Cl^--^ conductance at rest {#s3F}
-------------------------------------------------

Previous methods for estimating the relative Cl^--^ conductance of the neuronal membrane at rest have not been straight-forward and dependent on many assumptions ([@B22]). We here aimed at a method with which we could estimate the relative Cl^--^ conductance from voltage ramps applied under conditions with different Cl^--^ concentrations on the in- or outside of the membrane. The starting assumption was that the membrane current reversal potential could be described by the "conductance" version of the Goldman-Hodgkin-Katz equation ([@B25]; [@B32]; see, e.g., [@B41]): $$E_{rev} = (g_{K}/g_{T})E_{K} + (g_{Na}/g_{T})E_{Na} + (g_{Cl}/g_{T})E_{Cl}$$ where *E*~rev~ is the reversal potential for the total current, i.e., the resting potential, *g* is conductance with subscripts T, K, Na, and Cl for total, K^+^, Na^+^, and Cl^--^, respectively, and *E*~K~, *E*~Na~, and *E*~Cl~ are the equilibrium potentials for respective ions. From [Equation 1](#FD1){ref-type="disp-formula"}, we obtain $$g_{T}\, E_{rev} - g_{Cl}\, E_{Cl} = g_{K}\, E_{K} + g_{Na}\, E_{Na}$$

If we manipulate *E*~Cl~, e.g., by loading cells with Cl^--^ as described above, without changing ion conductances and without changing equilibrium potentials for Na^+^ and K^+^, then for the two conditions, before (subscript 1) and after (subscript 2) Cl^--^ loading, $$g_{T1}\, E_{rev1} - g_{Cl}\, E_{Cl1} = g_{T2}\, E_{rev2} - g_{Cl}\, E_{Cl2}$$ and if *g*~T~ does not change (as was experimentally verified, see below), then $$g_{T}\, E_{rev1} - g_{Cl}\, E_{Cl1} = g_{T}\, E_{rev2} - g_{Cl}\, E_{Cl2}$$

From [Equation 4](#FD4){ref-type="disp-formula"}, we obtain the relative Cl^--^ conductance: $$g_{Cl}/g_{T} = (E_{rev2} - \, E_{rev1})/(E_{Cl2} - \, E_{Cl1}) = \Delta E_{rev}/\Delta E_{Cl}$$

The relative Cl^--^ conductance may thus be obtained from the shift in reversal potential of total current relative to the shift in Cl^--^ equilibrium potential.

We here used continuous voltage ramp sequences, in a regular zigzag pattern, with application of glycine during part of the ramp sequence ([Fig. 1](#F1){ref-type="fig"}). By this procedure, estimates of conductance and reversal potential were obtained before as well as throughout the glycine application, with a time resolution determined by the ramp cycle frequency, here 20 Hz. The control ramps (i.e., before or in the absence of glycine application) were used to estimate total conductance (*g*~T~) and reversal potential (*E*~rev~), but also for subtraction of leak currents from the currents evoked by glycine to estimate (*E*~Cl~). A first set of *g*~T~, *E*~rev~ and *E*~Cl~ estimates were obtained from voltage ramps symmetrically around a holding potential of --74 mV (i.e., near the resting potential). Subsequently the holding voltage was raised to --14 mV (with ramps symmetrically around this voltage, as indicated in [Figure 1](#F1){ref-type="fig"}) and \[Cl^--^\]~i~ was raised by glycine (1.0 mM) application for 20 s. *E*~Cl~ was measured at the end of the 20-s glycine application (*E*~Cl~2~a~ in [Figure 1](#F1){ref-type="fig"}). Next, holding voltage was returned to --74 mV and a second estimate of *g*~T~ (*g*~T~2) and *E*~rev~ (*E*~rev~2) was obtained. A final estimate of *E*~Cl~ (*E*~Cl~2~b~) was made with ramps around a holding voltage of --34 mV. A linear interpolation between *E*~Cl~2~a~ and *E*~Cl~2~b~ was used to estimate *E*~Cl~ at the time of *g*~T~2 (and *E*~rev~2), to account for \[Cl^--^\]~i~ changes during this time interval. *g*~T~2 was compared with *g*~T~1 to verify that glycine-activated conductance had decayed and to satisfy the conditions for [Equation 4](#FD4){ref-type="disp-formula"}. Variations \<30% between the two measurements in the same cell were accepted (to account for fluctuations in resting conductance), and absence of any significant systematic difference was confirmed (see [Figure 5 below](#F5){ref-type="fig"}). These measurements were made with 100 µM Cd^2+^, to minimize transmitter release from adhering presynaptic terminals, and 30 mM TEA (replacing an equimolar amount of Na^+^ in the standard extracellular solution), to minimize voltage-gated K^+^ currents, tetrodotoxin (TTX; 2.0 µM), to block voltage-gated Na^+^ channels, and with the KCC2 blocker VU0255011-1 (10 µM) to minimize outward Cl^--^ transport between the times for measuring *E*~Cl~2~a~ and *E*~Cl~2~b~. To relate the derived resting *g*~Cl~ to the total membrane conductance in the absence of blockers, we also considered the effect of the used blockers on the total resting conductance *g*~T~. Control experiments showed that the total resting conductance in the presence of all four blockers (TEA, Cd^2+^, TTX, and VU0255011-1; *n =* 14) was, on average, only 54% (*p* = 0.0038, Mann--Whitney test) of that without blockers (*n =* 10). This effect could be ascribed to TEA and/or Cd^2+^ since the total conductance in a combination of TTX and VU0255011-1 (*n =* 14) was not significantly different from that without blockers (*n =* 10).

![Protocol used for estimation of relative Cl^--^ conductance at rest. ***A***, Voltage protocol (below in black/gray; ramp sequences appearing as blocks; for detailed ramps, see ***B***) and recorded current (top, red), with glycine application as indicated by the green bars (short bars, 100 µM; long bar, 1.0 mM). ***B***, Voltage protocol (bottom) and recorded current (top) for part of the ramp train shown within dashed box in ***A***.](enu0021722680001){#F1}

Computation of \[Cl^--^\]~i~ recovery time course {#s3G}
-------------------------------------------------

The time course of theoretically expected \[Cl^--^\]~i~ recovery was computed for a simplified model of a spherical one-compartment cell ([@B38]). The model included Cl^--^ transport mediated by KCC2 as well as Cl^--^ current through a leak conductance. \[Cl^--^\]~i~ was computed numerically according to $$\lbrack Cl^{-}\rbrack_{i}\,(t + \Delta t) = \lbrack Cl^{-}\rbrack_{i}\,(t) + \Delta\lbrack Cl^{-}\rbrack_{i,\, KCC2} + \Delta\lbrack Cl^{-}\rbrack_{i,\, conductive}$$ where $$\Delta\lbrack Cl^{-}\rbrack_{i,\, KCC2} = - \Delta t\,\Delta\mu_{K,Cl}\, g_{KCC2}\,{v_{equ}}^{- 1}\,(KCC2-mediated\, change\, in\,\lbrack Cl^{-}\rbrack_{i})$$

and $$\Delta\lbrack Cl^{-}\rbrack_{i,\, conductive} = I\Delta t\text{ F}^{- 1}\,{v_{equ}}^{- 1}\,(channel-mediated\, change\, in\,\lbrack Cl^{-}\rbrack_{i})$$ *t* is time, Δ*t* is the integration time step (here, 50 ms), *g*~KCC2~ is a transport proportionality factor ("apparent conductance", dependent on the number and transport capacity of KCC2 molecules) for KCC2, Δ*µ*~K,Cl~ is the driving force for KCC2: $$\Delta\mu_{K,Cl} = RT\,(ln(\lbrack Cl^{-}\rbrack_{i}/\lbrack Cl^{-}\rbrack_{o}) + ln(\lbrack K^{+}\rbrack_{i}/\lbrack K^{+}\rbrack_{o})),$$

and $$I = g_{Cl}\,(V_{m} - E_{Cl})\,\,\,\,\,\,\,\,({Cl}^{-}\, leak\, current),$$

F is the Faraday constant and v~equ~ is the equivalent volume, i.e., the cytosolic volume where Cl^−^ equilibrates, taken to be 50% of the total cell volume (here, assumed 5.0 10^−13^ l, i.e., 50% of the volume of a sphere of radius 6.2 µm; cf [@B38]). The proportionality factor *g*~KCC2~ was adjusted to match KCC2-mediated \[Cl^--^\]~i~ recovery to experimental results (experiments with minimized influence of *g*~Cl~, compare [Fig. 2*F*](#F2){ref-type="fig"}), whereas *g*~Cl~ was as experimentally recorded (compare [Figure 5 below](#F5){ref-type="fig"}). The computations were made using Turbo Basic software (Borland).

![\[Cl^--^\]~i~ loading and estimation of transporter-dependent recovery capacity. ***A***, Voltage protocol (bottom) and recorded current (top) during loading a cell with Cl^--^. Note that the baseline voltage during loading was --14 mV to obtain a large driving force for Cl^--^ current evoked by 1.0 mM GABA. Data from numbered ramps are shown in ***B*** and ***C***. ***B***, *I-V* relations corresponding to the ramps (no 1-4, 6, 8, as marked in ***A***) applied during Cl^--^ loading (corrected for series resistance and with leak components subtracted). ***C***, Time course of \[Cl^--^\]~i~ during Cl^--^ loading, as computed from *E*~Cl~ obtained from the *I-V* relations in ***B***, and superimposed fitted exponential curve. Resting \[Cl^--^\]~i~ was obtained from a separate, preceding ramp (not shown). ***D***, Voltage ramps (insets), leak and GABA-evoked currents used to probe \[Cl^--^\]~i~ during recovery after the end of Cl^--^ loading. Ramps for \[Cl^--^\]~i~ estimates at two different times are shown in ***Da*** and ***Db*** (compare *I*-*V* relations in ***E***). ***E***, *I-V* relations from probe currents as in ***D*** (with the relations corresponding to currents in ***Da*** and ***Db*** indicated). Note that *I-V* relations are shifted with time to more negative voltages, as a consequence of the changing \[Cl^--^\]~i~ and *E*~Cl~. ***F***, Full-time course of \[Cl^--^\]~i~ changes during loading (first 25 s) and recovery phases with superimposed mono-exponential fit (red thick line) of the recovery phase.](enu0021722680002){#F2}

Statistical analysis {#s3H}
--------------------

Data are presented as the mean ± SEM, with *n* representing the number of cells studied. Differences between groups were analyzed with the paired Wilcoxon signed-rank test for paired data and with the Mann--Whitney test for unpaired data; *p* \< 0.05 was considered statistically significant. Statistical analyses were performed using the software OriginPro 2016 (OriginLab).

Results {#s4}
=======

Transporter-dependent recovery of \[Cl^--^\]~i~ {#s4A}
-----------------------------------------------

To obtain an overall view of the \[Cl^--^\]~i~ recovery capacity in dissociated medial preoptic nucleus (MPN) neurons, we first addressed transporter-dependent recovery after a Cl^--^ load to concentrations significantly above baseline \[Cl^--^\]~i~, previously estimated to ∼9 mM in this preparation ([@B38]). To estimate the capacity, we loaded the cells with Cl^--^ by combined depolarization and GABA or glycine application. This resulted in an exponential (time constant 3.8 ± 0.4 s, *n =* 19) increase in \[Cl^--^\]~i~ to 60 ± 3 mM (*n =* 19; [Fig. 2*A-C*](#F2){ref-type="fig"}). After loading, \[Cl^--^\]~i~ recovery was studied by voltage ramps (to estimate *E*~Cl~) given from a holding potential that was kept as close as possible to the gradually changing *E*~Cl~, to minimize influence of passive conductive recovery and also to minimize influence of the GABA/glycine applications during recovery ([Fig. 2*D*,*E*](#F2){ref-type="fig"}). This required test runs to obtain a rough estimate of the *E*~Cl~ recovery time course. Under these conditions, favoring mainly nonconductive, transporter-dependent changes, \[Cl^--^\]~i~ recovery varied somewhat between cells, following a roughly exponential, a doubly exponential or a nearly linear time course ([Fig. 2*F*](#F2){ref-type="fig"}). For simplicity, we used the best fitted single-exponential for comparison between cells and recording conditions. In control conditions, the time constant was 499 ± 49 s (*n =* 19). Since the recovery time course was considerably slower than estimated for some other cell types, and with other techniques ([@B61]; [@B69]; [@B23]; [@B53]; [@B16]), we made a few recordings from neurons dissociated from the CA1 region in brain slices containing the hippocampus. However, in the three hippocampal cells tested, \[Cl^--^\]~i~ recovery occurred with a time constant of 1877 ± 60 s, thus even slower than for the MPN neurons.

To verify that the \[Cl^--^\]~i~ recovery described was mediated by transporter activity, we applied several types of blockers. The time course of recovery was not significantly affected by a blocker (bumetanide, 10 µM) of the Na^+^-K^+^-Cl^--^ cotransporter 1 (NKCC1; [Fig. 3*A*,*D*](#F3){ref-type="fig"}) but was dramatically slowed by furosemide (0.5 mM; [Fig. 3*B*,*D*](#F3){ref-type="fig"}), which affects also KCC2, as well as by the selective KCC2 blocker VU0255011-1 (10 µM; [Fig. 3*C*,*D*](#F3){ref-type="fig"}). These effects are consistent with the idea that a major fraction of the observed recovery is mediated by KCC2. The kinetic details of transporter-dependent \[Cl^--^\]~i~ recovery were not investigated further here.

![Pharmacology of transporter-mediated recovery of \[Cl^--^\]~i~. ***A***--***C***, \[Cl^--^\]~i~ recovery under control conditions (black filled circles) and in the presence of 10 µM bumetanide (***A***, red open circles), 0.5 mM furosemide (***B***, blue open circles), and 10 µM VU0255011-1 (***C***, orange open circles), with control and drug application for the same cell. Cl^--^ was loaded and \[Cl^--^\]~i~ quantified as in Figure 2. ***D***, Summary of drug effects on the level of \[Cl^--^\]~i~ after 10 min recovery, measured as \[Cl^--^\]~i~ normalized to maximal \[Cl^--^\]~i~ during Cl^--^ loading. Note the lack of significant effect of the NKCC1-blocker bumetanide but highly significant effects of the KCC2 blockers furosemide and VU0255011-1.](enu0021722680003){#F3}

Passive, conductive recovery of \[Cl^--^\]~i~ {#s4B}
---------------------------------------------

If a substantial conductive component contributes to \[Cl^--^\]~i~ recovery, this should be seen as a voltage-dependent component. KCC2-mediated Cl^--^ transport does not depend on voltage (see, e.g., [@B73]). We therefore studied \[Cl^--^\]~i~ recovery as above, but with membrane voltage kept at either --14 or --74 mV during the recovery phase. Test pulses of GABA/glycine were still applied at a holding voltage close to *E*~Cl~, to minimize GABA/glycine-induced Cl^--^ flux. The time at these voltages was, however, very small compared with the total recovery time. The recovery time constant observed at --14 mV was 843 ± 208 s (*n =* 8), significantly (*p* = 0.0078; paired Wilcoxon signed-rank test) longer than that at --74 mV (375 ± 95 s; *n =* 8) in the same cells. The difference obtained by changing the holding voltage was reversible ([Fig. 4*A*,*B*](#F4){ref-type="fig"}). In addition, \[Cl^--^\]~i~ recovered to a lower level (4.3 ± 1.2 mM, *n =* 8) at --74 mV than at --14 mV (10.9 ± 3.0 mM; *n =* 8; *p* = 0.039; evaluated from the asymptote of the fitted exponential function). Thus, the data are compatible with a substantial contribution of conductive Cl^--^ flux to \[Cl^--^\]~i~ recovery.

![Effect of voltage on \[Cl^--^\]~i~ recovery. ***A***, \[Cl^--^\]~i~ recovery in an individual cell at two different levels of holding voltage, as indicated, in control solution. Note that \[Cl^--^\]~i~ recovers quicker and to a lower concentration at --74 mV compared with at --14 mV. ***B***, Summary of data showing \[Cl^--^\]~i~ recovery at --74 and at --14 mV (as in ***A***) in eight neurons. ***C***, \[Cl^--^\]~i~ recovery in an individual cell at two different levels of holding voltage, as indicated, in the presence of 10 µM VU0255011-1. ***D***, Summary of data showing \[Cl^--^\]~i~ recovery at --74 and at --14 mV in the presence of 10 µM VU0255011-1 (as in ***C***) in five neurons. Probe pulses to estimate \[Cl^--^\]~i~ were given at slightly different times during each recovery interval (to keep the membrane potential close to *E*~Cl~). To compare at similar times, in ***B*** and ***D***, interpolation was used for data pairs closest to the time points illustrated, and \[Cl^--^\]~i~ was normalized to the maximal concentration during loading.](enu0021722680004){#F4}

To quantify the conductive component of \[Cl^--^\]~i~ recovery in isolation, we repeated the experiments with different holding voltages in the presence of the KCC2 blocker VU0255011-1 (10 µM): There was only little recovery (7.9 ± 2.7% of the loaded \[Cl^--^\]~i~ recovered after 20 min; *n =* 5) at --14 mV, whereas at --74 mV, \[Cl^--^\]~i~ recovered with a time constant of 651 ± 171 s (*n =* 5) and 60 ± 5% of the \[Cl^--^\]~i~ increase during loading was eliminated after 20 min of recovery ([Fig. 4*C*,*D*](#F4){ref-type="fig"}). Thus, it is clear that without KCC2 there is very small, if any, Cl^--^ extrusion capacity to counteract the effect of conductive Cl^--^ transport on \[Cl^--^\]~i~ at --14 mV and that at --74 mV, conductive Cl^--^ transport accounts for a recovery time course in the same order of magnitude as does KCC2 in the absence of blockers (compare [Fig. 3](#F3){ref-type="fig"}, black filled symbols, with [Fig. 4*D*](#F4){ref-type="fig"}, brown filled symbols).

Estimate of resting Cl^--^ conductance {#s4C}
--------------------------------------

From above, it is clear that although KCC2 is required for a rapid and complete recovery of \[Cl^--^\]~i~ to normal resting levels, a significant recovery takes place also by passive, conductive pathways in the absence of functional KCC2. The rate of such recovery will depend on the conductance to Cl^--^, *g*~Cl~. Resting *g*~Cl~ will also be an important determinant of resting \[Cl^--^\]~i~ ([@B36]). We therefore derived a method for estimating the resting *g*~Cl~, as described in Materials and Methods and [Figure 1](#F1){ref-type="fig"}. Since the method depends on a total membrane conductance, *g*~T~, that does not change with Cl^--^ loading, we first verified that *g*~T~ before (*g*~T~1) and shortly after (*g*~T~2) Cl^--^ loading was not significantly different ([Fig. 5*A*](#F5){ref-type="fig"}). Subsequently, we computed the relative resting *g*~Cl~, from [Equation 4](#FD4){ref-type="disp-formula"} and the conductance and reversal potential measures obtained as described in [Figure 1](#F1){ref-type="fig"}. A final computation accounted for the effect of used background blockers (TEA, Cd^2+^, TTX, and VU0255011-1) on the total membrane conductance (see Materials and Methods). The obtained relative resting *g*~Cl~ was 6.0 ± 1.4% (*n =* 12; relative to total resting conductance in the absence of blockers), corresponding to an absolute resting *g*~Cl~ of 54 ± 13 pS (*n =* 12).

![Relative resting Cl^--^ conductance. ***A***, Distribution of measured total conductances (in the presence of VU0255011-1, TTX, Cd^2+^, and TEA; see main text), showing no significant difference before and after Cl^--^ loading, as required for the method used to estimate resting Cl^--^ conductance. Data paired for individual cells. ***B***, Relative resting Cl^--^ conductance, in control conditions and in the presence of 100 µM PTX. Note that the given values in ***B*** are relative to the total membrane conductance in the absence of blockers.](enu0021722680005){#F5}

We next addressed the molecular basis for the resting *g*~Cl~. We first tested the hypothesis that open GABA~A~ receptors accounted for part of *g*~Cl~. Relative resting *g*~Cl~ obtained from experiments with PTX (100 µM) added to the external solution was only 2.2 ± 1.4% (*n =* 12; [Fig. 5*B*](#F5){ref-type="fig"}), or ∼37% of that without PTX. Since 200 µM PTX does not significantly affect the near-steady glycine-evoked current in the studied cell type ([@B38]), this suggests that GABA~A~ receptors account for a major fraction of resting *g*~Cl~.

ClC-2 channels do not contribute significantly to resting conductance in MPN neurons {#s4D}
------------------------------------------------------------------------------------

Because Cl^--^-permeable ClC-2 channels have been reported to contribute substantially to the resting conductance in CA1 pyramidal cells ([@B53]), we used a voltage protocol suitable for detection of Cl^--^ currents through ClC-2 channels ([Fig. 6*A*](#F6){ref-type="fig"}, bottom) to establish whether the MPN neurons express such channels. However, the current responses in eight cells tested were only composed of linear capacitive and small leak currents in the relevant voltage range ([Fig. 6*A*](#F6){ref-type="fig"}, top, *B*), making it unlikely that ClC-2 contributes significantly to the resting conductance in MPN neurons.

![Lack of ClC-2 currents. ***A***, Voltage protocol (bottom) used for detecting ClC-2 currents and corresponding currents (top) recorded in an MPN neuron. Colors of individual current traces matches the colors in the voltage protocol. ***B***, *I*-*V* relation for the currents in ***A*** (average amplitude during the time marked by olive bar in ***A***). Note the small amplitude and the linearity in the range below --65 mV.](enu0021722680006){#F6}

Contribution of GABA~A~ receptors to conductive \[Cl^--^\]~i~ recovery {#s4E}
----------------------------------------------------------------------

The above results show that there is a significant resting Cl^--^ conductance in MPN neurons and suggest that a major fraction of this conductance is due to GABA~A~ receptors. We therefore expected that GABA~A~ receptors may contribute to \[Cl^--^\]~i~ recovery after a high Cl^--^ load. In dissociated MPN neurons, GABA~A~ receptors may be activated as a consequence of spontaneous GABA release from adhering presynaptic nerve terminals ([@B28]). We speculated that possibly such spontaneous GABA release could contribute to *g*~Cl~ and \[Cl^--^\]~i~ recovery. To clarify this, we studied the time course of conductive \[Cl^--^\]~i~ recovery (i.e., in the presence of 10 µM VU0255011-1 to block KCC2) under voltage-clamp conditions at --74 mV. A few control recordings showed that in the absence of additional blockers, a roughly similar time course of \[Cl^--^\]~i~ recovery is seen under current-clamp conditions at zero current ([Fig. 7*A*](#F7){ref-type="fig"}). We first compared \[Cl^--^\]~i~ recovery at --74 mV without and with TTX (2.0 µM) to block action potential-evoked release of GABA, however, without noting any significant difference ([Fig. 7*A*](#F7){ref-type="fig"}). We subsequently added 3.0 µM gabazine (SR-95531 hydrobromide), previously shown to block spontaneous IPSCs in the studied cell type ([@B38]), but also this was without significant effect on conductive \[Cl^--^\]~i~ recovery, as was also the glycine-receptor blocker strychnine (10 µM; [Fig. 7*A*](#F7){ref-type="fig"}). The lack of effect of gabazine was somewhat surprising in light of the above suggested contribution of GABA~A~ receptors to resting *g*~Cl~. However, while PTX, which was used above for resting *g*~Cl~, is noncompetitive and usually considered as a pore blocker ([@B64]; [@B21]), gabazine is a competitive GABA~A~ receptor antagonist ([@B30]; [@B29]) and may fail to block receptor-channels that are spontaneously open in the absence of GABA ([@B9]; [@B71]). Indeed, consistent with the effect of PTX on resting *g*~Cl~, PTX significantly reduced conductive \[Cl^--^\]~i~ recovery in the studied 10-min interval ([Fig. 7*B*](#F7){ref-type="fig"}), suggesting that spontaneously open GABA~A~ receptors in the absence of GABA do contribute to recovery.

![Role of spontaneously open GABA~A~ receptors and of neurosteroid-potentiated mIPSCs for \[Cl^--^\]~i~ recovery. ***A***, Relative \[Cl^--^\]~i~, illustrating recovery 5 and 10 min after Cl^--^ loading. Current-clamp (0 pA) between test ramps during recovery phase: control only. Voltage-clamp (--74 mV) between test ramps during recovery phase: control, 2.0 µM TTX, 3.0 µM gabazine, a combination of TTX and gabazine, or 10 µM strychnine, as indicated. Note the lack of significant differences. ***B***, Relative \[Cl^--^\]~i~ (as in ***A***, voltage-clamp only), with significantly reduced recovery in the presence of 100 µM PTX. ***C***, Relative \[Cl^--^\]~i~ (as in ***B***), showing gabazine-sensitive enhancement of recovery in the presence of 2.0 µM TTX and the neurosteroid allopregnanolone (Allo) in a concentration (20 nM) known to enhance mIPSC frequency and prolong mIPSC decay. ***D***, Relative \[Cl^--^\]~i~ (as in ***B***) showing the dramatic enhancement of \[Cl^--^\]~i~ recovery by allopregnanolone in a concentration (1.0 µM) that may directly activate GABA~A~ receptors and the block of this effect by 100 µM PTX. ***E***, Comparison of the effects of 20 nM Allo, DS2 and a combination of Allo and DS2 on normalized \[Cl^--^\]~i~ after 5 min of recovery from a Cl^--^ load as in ***A***--***D***. Note the highly significant effect of DS2 and the additive effects of Allo and DS2. To compare data recorded at slightly different times in ***A***--***E***, interpolation was used for data pairs closest to the time points illustrated and \[Cl^--^\]~i~ was normalized to the maximal concentration during loading.](enu0021722680007){#F7}

Neurosteroid regulates conductive \[Cl^--^\]~i~ recovery via miniature IPSCs (mIPSCs) {#s4F}
-------------------------------------------------------------------------------------

Although the above results suggested that spontaneous, action potential-independent GABA release does not significantly affect \[Cl^--^\]~i~ recovery, we hypothesized that such release and the generated mIPSCs may still play a physiologic role for the Cl^--^ homeostasis. Hypothetically, mIPSC potentiation by an endogenous modulator may enable such a functional role for the spontaneously released transmitter. The endogenous neurosteroid 3α-hydroxy-5α-pregnane-20-one (allopregnanolone), which may be produced *de novo* in the brain, e.g., during stress ([@B49]), increases the frequency as well as prolongs the decay time of mIPSCs in MPN neurons ([@B27]). We therefore analyzed the effect of allopregnanolone on \[Cl^--^\]~i~ recovery at --74 mV in the presence of 10 µM VU0255011-1 to block KCC2. It was clear that, in the presence of TTX (2.0 µM) to block action potential-evoked GABA release, 20 nM allopregnanolone, a concentration that mainly affects the time course of mIPSCs ([@B26]) and may be reached *in vivo* ([@B49]), significantly potentiated \[Cl^--^\]~i~ recovery as quantified 5 min after loading with Cl^--^ ([Fig. 7*C*](#F7){ref-type="fig"}). This effect of allopregnanolone was abolished by gabazine (3.0 µM; [Fig. 7*C*](#F7){ref-type="fig"}), suggesting that the steroid effect was mediated by GABA~A~ receptors that were activated by GABA, as expected for mIPSCs. Allopregnanolone at 20 nM concentration did not affect the baseline current in 11 cells tested (*p* = 0.55; paired sample Wilcoxon signed-rank test), ruling out significant effects on tonic GABA~A~ receptor-mediated currents at this steroid concentration.

Higher, micromolar concentrations of allopregnanolone may directly activate GABA~A~ receptors in MPN neurons ([@B27]). Here, the effect of 1.0 µM allopregnanolone on \[Cl^--^\]~i~ recovery was dramatic and highly significant ([Fig. 7*D*](#F7){ref-type="fig"}, compare top and lower curves). The effect was abolished in the presence of 100 µM PTX, confirming an action on GABA~A~ receptors ([Fig. 7*D*](#F7){ref-type="fig"}).

It seems possible that some of the effect of 1.0 µM allopregnanolone may be mediated by δ-subunit-containing GABA~A~ receptors, which are extra- or peri-synaptically located and highly sensitive to potentiation by neuroactive steroids ([@B74]). They may also display a degree of spontaneous activity ([@B35]; [@B71]) that should contribute to the background Cl^--^ conductance. We took advantage of the positive allosteric modulator δ-selective compound 2 (DS2; [@B68]; [@B35]), which, although not perfectively selective, may preferentially potentiate δ-subunit-containing GABA~A~ receptors at concentrations \<2 µM ([@B2]). Here, DS2 (1.0 µM) significantly enhanced the \[Cl^--^\]~i~ recovery as measured 5 min after loading with Cl^--^ ([Fig. 7*E*](#F7){ref-type="fig"}), suggesting that \[Cl^--^\]~i~ recovery may be pharmacologically enhanced via positive modulation of δ-subunit-containing GABA~A~ receptors. This effect was additive to the effect of 20 nM allopregnanolone ([Fig. 7*E*](#F7){ref-type="fig"}).

Theoretically expected influence of conductive Cl^--^ flux on \[Cl^--^\]~i~ recovery {#s4G}
------------------------------------------------------------------------------------

The experimental results described above show that MPN neurons display a resting Cl^--^ conductance that contributes significantly to recovery of \[Cl^--^\]~i~ after a high Cl^--^ load. To clarify the theoretically expected contribution of the resting *g*~Cl~ to \[Cl^--^\]~i~ recovery, we used the model described by [@B38] to compute the time course of \[Cl^--^\]~i~. In essence, the influence of relative *g*~Cl~ and of the KCC2-mediated transport capacity (*g*~KCC2~) was analyzed in a single-compartment cell with dimensions, total resting conductance and ion (external K^+^ and Cl^--^, internal K^+^) concentrations matching experimental values (see Materials and Methods). The time course of computed \[Cl^--^\]~i~ recovery mediated by KCC2 in the absence of resting *g*~Cl~ was matched to the experimental results ([Fig. 2*F*](#F2){ref-type="fig"}, control; experiment with minimized influence of *g*~Cl~) by adjusting *g*~KCC2~ ([Fig. 8*A*](#F8){ref-type="fig"}, red, middle).

![Computed \[Cl^--^\]~i~ recovery. Dependence on *g*~Cl~, *g*~KCC2~, and *V*~m~. ***A***, Recovery mediated by KCC2 only (red, middle), Cl^--^ leak only (blue, top), or a combination of KCC2 and Cl^--^ leak (black, bottom) at *V*~m~ = --74 mV. ***B***, Recovery mediated by KCC2 and Cl^--^ leak in combination at different *V*~m~, as indicated. Note that the rate of recovery as well as the asymptotic steady-state \[Cl^--^\]~i~ depends on *V*~m~. ***C***, Recovery mediated by KCC2 and Cl^--^ leak in combination at different relative *g*~Cl~, as indicated and at *V*~m~ = --74 mV (***Ca***) or *V*~m~ = --50 mV (***Cb***). Note that the speed of recovery increases with *g*~Cl~ and that the asymptotic steady-state \[Cl^--^\]~i~ also increases with *g*~Cl~. The latter effect is weak at --74 mV (***Ca***) but prominent at --50 mV (***Cb***). The transport capacity of KCC2 in (***A--C***) was adjusted by setting the transporter proportionality factor (apparent conductance; [@B36]) *g*~KCC2~ to 6.7 10^−21^ mol^2^ V^−1^ C^−1^ s^−1^, to match modeled KCC2-mediated \[Cl^--^\]~i~ recovery time course to experimental results.](enu0021722680008){#F8}

Assuming a relative resting *g*~Cl~ of 6.0% (of a total conductance of 0.89 nS in blocker-free conditions, to match the experimentally obtained conductance of 0.48 nS in [Figure 5*A*](#F5){ref-type="fig"}, left, and the effect of the used blockers on *g*~T~ as described in Materials and Methods), but no KCC2-mediated transport resulted in a computed \[Cl^--^\]~i~ recovery (at --74 mV) that reasonably well matched the experimental recovery ([Fig. 4*D*](#F4){ref-type="fig"}, lower curve) observed with KCC2 blocked ([Fig. 8*A*](#F8){ref-type="fig"}, blue, top). The computed \[Cl^--^\]~i~ recovery with *g*~Cl~ as well as KCC2-mediated transport ([Fig. 8*A*](#F8){ref-type="fig"}, black, bottom) was quicker, showing that even with a relative resting *g*~Cl~ as low as 6.0%, a substantial effect on \[Cl^--^\]~i~ is indeed expected. It is also clear that \[Cl^--^\]~i~ settles at a slightly higher steady level due to the combined effects of *g*~Cl~ and KCC2 as compared with KCC2-mediated transport only ([Fig. 8*A*](#F8){ref-type="fig"}, black, bottom). It was recently shown that, in a cell where \[Cl^--^\]~i~ is determined by *g*~Cl~ and *g*~KCC2~, at steady-state, *E*~Cl~ will settle between the membrane potential and the equilibrium potential for K^+^, depending on the relative influence of *g*~Cl~ and of *g*~KCC2~ ([@B36]). As shown here ([Fig. 8*B*](#F8){ref-type="fig"}), the membrane potential (*V*~m~) influences the rate of \[Cl^--^\]~i~ recovery as well as the steady-state \[Cl^--^\]~i~. As *g*~Cl~ drives *E*~Cl~ toward *V*~m~, there is a trade-off between the rate of \[Cl^--^\]~i~ recovery (maximal at high *g*~Cl~) and the steady-state \[Cl^--^\]~i~ (minimal at low *g*~Cl~). The effect of *g*~Cl~ on steady-state \[Cl^--^\]~i~ is small at strongly negative *V*~m~ (--74 mV; [Fig. 8*Ca*](#F8){ref-type="fig"}) but prominent at less negative *V*~m~ (--50 mV; [Fig. 8*Cb*](#F8){ref-type="fig"}). It is clear from [Figure 8*C*](#F8){ref-type="fig"} that, at more negative potentials in particular, there is a strong potential to modulate the rate of \[Cl^--^\]~i~ recovery by substances that affect *g*~Cl~, such as neuroactive steroids or GABA~A~ receptor active compounds like DS2 and PTX. At more positive potentials, in particular, there is also a potential to modulate resting \[Cl^--^\]~i~ by such substances.

Discussion {#s5}
==========

In the present study, we have used voltage-ramp techniques to analyze how passive, conductive Cl^--^ flux contributes to \[Cl^--^\]~i~ recovery after a significant Cl^--^ load introduced in central neurons. We have also compared with \[Cl^--^\]~i~ recovery mediated by the transporter KCC2 and showed that conductive flux may account for a contribution in the same order of magnitude as KCC2. To estimate the relative resting Cl^--^ conductance, for which little information is available concerning central mammalian neurons, we developed a novel technique based on \[Cl^--^\]~i~ perturbation. We showed a relative resting Cl^--^ conductance of 6%, with a major fraction mediated by open GABA~A~ receptors. We also showed that conductive \[Cl^--^\]~i~ recovery may be dramatically potentiated by the endogenous neurosteroid allopregnanolone, acting by enhancing the frequency and prolonging the time course of miniature postsynaptic currents. This suggests a novel role for neurosteroids in Cl^--^ homeostasis as well as a novel role for spontaneous transmitter release.

KCC2-mediated \[Cl^--^\]~i~ recovery in isolated preoptic neurons {#s5A}
-----------------------------------------------------------------

The time constant of \[Cl^--^\]~i~ recovery in the studied MPN neurons was considerably longer than the few seconds reported in some earlier studies ([@B61]; [@B69]; [@B23]; [@B53]; [@B16]), including studies of hippocampal CA1 neurons, where whole-cell recording or sharp microelectrodes were used. The recordings we made from hippocampal neurons showed a still slower \[Cl^--^\]~i~ recovery, suggesting that the difference from the earlier studies did not depend on the cell type, but likely on the recording techniques or type of preparational procedures. It seems likely that earlier studies with sharp microelectrodes or whole-cell recording may not have fully accounted for the introduced Cl^--^ leak to/from the outside or equilibration with the patch pipette, the latter which may occur within a few seconds ([@B50]). Further, the negative holding voltage used in some studies implies that conductive \[Cl^--^\]~i~ recovery may have contributed significantly, whereas we reduced influence of conductive recovery by changing the holding voltage gradually while transporter-mediated recovery was estimated. Indeed, studies using the gramicidin-perforated patch technique report a slower recovery (\>30 s up to several minutes; [@B13]; [@B43]; [@B48]). Also measurements with optical Cl^--^ sensors suggest a recovery time constant of ∼30 s ([@B7]) or several minutes ([@B24]), although conductive recovery may have contributed also there. On the other hand, possibly the KCC2-mediated transport is dependent on the naturally surrounding milieu, which was largely eliminated by the dissociation process in the present work. Clearly, dendrites were removed in the present study. The \[Cl^--^\]~i~ fluctuations in dendrites are expected to be much quicker than in the cell body ([@B17]). Therefore, the presently reported time course of \[Cl^--^\]~i~ recovery should be interpreted as reflecting the KCC2-dependent transport capacity of isolated neuronal cell bodies.

Conductive \[Cl^--^\]~i~ recovery {#s5B}
---------------------------------

For any cell with a significant Cl^--^ permeability, a raised cellular \[Cl^--^\]~i~ is expected to recover by conductive pathways to a level determined in part by the membrane potential. To our knowledge, such recovery has previously not been rigorously quantified. We here showed that, surprisingly, conductive \[Cl^--^\]~i~ recovery at negative holding potentials was substantial, with a time course roughly similar to the time course of isolated KCC2-dependent recovery. This implies that the gain in speed of recovery contributed by KCC2 is not dramatic, if a sufficiently negative resting potential can be maintained. Nevertheless, KCC2 has been shown important for nervous function, with reduced KCC2 function being associated with several types of pathology, such as neuropathic pain ([@B15]), epilepsy ([@B33]), autism ([@B67]; [@B44]), schizophrenia ([@B44]), spasticity ([@B12]), and ischemia ([@B34]). There are several possibilities as to why KCC2 may be needed despite substantial conductive recovery. First, conductive recovery is dependent on the membrane potential, *V*~m~. Thus, when *V*~m~ is raised, e.g., as a consequence of ongoing excitatory synaptic activity, conductive Cl^--^ flux will drive \[Cl^--^\]~i~ toward a higher level, where *E*~Cl~ equals the momentary *V*~m~. In this respect, conductive Cl^--^ flux may contribute to loading of Cl^--^ at raised *V*~m~ (as it does during the loading procedure used in the present work). Thus, KCC2 may be crucial in conditions of raised *V*~m~. Second, even at the resting potential in the absence of synaptic depolarization, conductive \[Cl^--^\]~i~ recovery cannot lower *E*~Cl~ beyond the membrane potential, and thus not sufficiently to produce hyperpolarizing GABA or glycine responses. The slight HCO~3~ ^--^ permeability of GABA~A~ and glycine receptors implies that extra lowering of *E*~Cl~ is needed for hyperpolarizing responses. Although GABA and glycine could still mediate shunting inhibition, it seems possible that hyperpolarizing responses may be of advantage in some conditions, due, e.g., to the different distribution in time and space of hyperpolarization and the underlying conductance change ([@B37]). Third, the contribution by KCC2 to \[Cl^--^\]~i~ recovery, even if small, still may be crucial to normal neural function. The finding that even mild KCC2 hypofunction may degrade neural coding ([@B18]) supports this possibility. Since conductive \[Cl^--^\]~i~ recovery may be of a similar magnitude as KCC2-dependent recovery, it seems likely that it will also be critical for neural coding and that reduced conductive recovery may be associated with pathology. Further, the potential for modulation of \[Cl^--^\]~i~ recovery via altered *g*~Cl~, as illustrated in [Figure 8*Ca*](#F8){ref-type="fig"}, suggests that the levels of neuroactive steroids or the presence of other GABA~A~ receptor active substances, such as DS2, may be expected to affect the degree of disturbance in \[Cl^--^\]~i~-related pathologic conditions.

The expression of Cl^--^ transporters and \[Cl^--^\]~i~ change during development, with fetal and early postnatal stages dominated by a low expression of KCC2, but a relatively high expression of NKCC1 and a relatively high \[Cl^--^\]~i~ (see, e.g., [@B6]). If \[Cl^--^\]~i~ is to be maintained lower than dictated by the thermodynamic equilibrium for NKCC1 (usually \>60 mM), NKCC1 must be opposed by outward Cl^--^ flux. In the absence of Cl^--^ extruding transporters, the resting *g*~Cl~ in combination with a negative resting potential may account for such outward Cl^--^ flux. Thus, we may expect that conductive \[Cl^--^\]~i~ recovery plays a relatively larger role early in development and in other situations when KCC2 expression is low, compared with when KCC2 expression is high.

Resting Cl^--^ conductance {#s5C}
--------------------------

The rate of conductive \[Cl^--^\]~i~ change will necessarily depend on the membrane Cl^--^ conductance, *g*~Cl~. Neuronal membranes are permeable to Cl^--^ even at rest ([@B55]; [@B63]), but for mammalian neurons, information on the quantity of the resting Cl^--^ permeability or *g*~Cl~ is scarce. Such information is needed not only to understand recovery of a perturbed \[Cl^--^\]~i~. The background *g*~Cl~ is also critically influencing neuronal firing properties, such as action potential frequency adaptation and "after discharge", and the control of cell volume ([@B8]). [@B22] calculated the approximate resting *g*~Cl~ in spinal motorneurons to 18% of the total (Na^+^, K^+^, and Cl^--^) conductances, but their estimate depended on several assumptions, including unknown changes in K^+^ conductance, and they emphasize the obstacles to estimation introduced by the complex neuronal morphology. In the present work, the latter type of obstacles was avoided by using isolated neuronal cell bodies. Further, the novel method we developed for quantifying *g*~Cl~ employed a simple expression ([Eq. 5](#FD5){ref-type="disp-formula"}), which depended mainly on the testable and verified assumption of constant total conductance in the experimental conditions used. The obtained resting *g*~Cl~ was relatively low (mean relative *g*~Cl~ 6% and absolute *g*~Cl~ 54 pS), with a major (∼2/3) contribution by GABA~A~ receptors, as suggested by the reducing effect of PTX. This corresponds to the conductance of only two open GABA~A~ receptor channels (with most frequent single-channel conductance of 17 pS; [@B11]). Since the presence of δ-subunit-containing GABA~A~ receptors, which may contribute to tonic currents ([@B35]; [@B71]), was suggested above (see Results), it seems likely that such receptors contribute to the GABA~A~ receptor-mediated fraction of *g*~Cl~ and \[Cl^--^\]~i~ recovery. The novel method used here to estimate resting *g*~Cl~ could easily be applied also to many other preparations. It may be noted that manipulating Cl^--^ concentrations in the external solution may in many cases provide a useful alternative to loading cells with Cl^--^, as done here.

A significant contribution of glycine receptors to the resting *g*~Cl~ seems unlikely for several reasons. First, the competitive glycine-receptor blocker strychnine did not affect \[Cl^--^\]~i~ recovery ([Fig. 7*A*](#F7){ref-type="fig"}). Second, in contrast to some GABA~A~ receptors, glycine receptors do not show any significant degree of spontaneous openings in the absence of ligand ([@B66]; [@B4]; [@B10]).

Although ClC-2 channels seem to play a large role for the background conductance in CA1 pyramidal cells ([@B53]), we did not find evidence for such channels in MPN neurons. Thus, it is unlikely that they contribute to resting *g*~Cl~ in these neurons. In cells where ClC-2 channels are present, their contribution to *g*~Cl~ may be expected to enhance the impact of conductive \[Cl^--^\]~i~ recovery even beyond that described in the present work. This may be of particular importance if the ClC-2-containing neurons show a limited transporter-dependent recovery capacity, such as indicated by our recordings from hippocampal neurons in the present study.

Role of minis and neurosteroids in Cl^--^ homeostasis {#s5D}
-----------------------------------------------------

Spontaneous neurotransmitter release may possibly play a special role in the control of conductive \[Cl^--^\]~i~ changes. The small postsynaptic currents generated do most often not induce major voltage fluctuations ([@B45]; [@B57]; [@B54]). Accordingly, our results showed that, in control conditions, spontaneously released GABA does not significantly affect the recovery of \[Cl^--^\]~i~ after a high load. However, postsynaptic currents generated by GABA release onto MPN neurons may be prolonged by the action of the endogenous neurosteroid allopregnanolone ([@B27]). We here showed that in the presence of a concentration (20 nM) that has been detected *in vivo* when animals are exposed to stress ([@B49]), allopregnanolone significantly enhances the speed of \[Cl^--^\]~i~ recovery. Thus, the neurosteroid has the capacity to control \[Cl^--^\]~i~ dynamics in a situation when raised \[Cl^--^\]~i~ seems particularly likely, as a result of stress-induced enhancement of neural activity. Although a stress-induced reduction of inhibition may be important for, e.g., corticotrophin-releasing hormone neurons ([@B31]), it seems likely that other neurons may need a maintained functional inhibition during stress and that allopregnanolone may facilitate this via enhanced conductive \[Cl^--^\]~i~ recovery. Similarly, neurosteroid-induced enhancement of \[Cl^--^\]~i~ recovery may likely partly compensate for low levels of KCC2. However, as shown in our computations ([Fig. 8*C*](#F8){ref-type="fig"}), in such situations there will be a trade-off between the rate of recovery and the minimum steady-state \[Cl^--^\]~i~.

The observed effect of 20 nM allopregnanolone on \[Cl^--^\]~i~ recovery can be ascribed to the postsynaptic currents (mIPSCs) generated by spontaneously released GABA, since baseline current was not affected. At micromolar concentrations, allopregnanolone directly activates GABA~A~ receptors as well as potentiates mIPSC frequency and prolongs mIPSC decay in MPN neurons ([@B27]). In other cells, direct activation of GABA~A~ receptors may occur at 100 nM allopregnanolone ([@B59]), a concentration that may be reached during pregnancy ([@B47]), suggesting that steroid modulation of \[Cl^--^\]~i~ homeostasis via resting *g*~Cl~ through direct GABA~A~ receptor activation may be expected under physiologic conditions. Neurosteroid-controlled regulation of Cl^--^ homeostasis via the channels opened by spontaneously released GABA may possibly provide a novel functional role for spontaneous neurotransmission.

Synthesis {#s6}
=========

Reviewing Editor: Alfonso Araque, University of Minnesota

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: Charles Zorumski, Andrea Barberis

Both reviewers are postitive about the manuscript and largely satisfied with the responses to the criticisms about the previous version reviewed in J Neurosci.

However, they have some concerns that need to be addressed and that I believe will enhance the strength of the manuscript.

I am looking forward to receive the revised version of the manuscript.

Specific comments of the reviewers:

Reviewer 1.

General comment:

The role of GABA receptors in the resting conductance of neurons is an understudied topic of importance in understanding factors that regulate basal neuronal excitability. The authors present a systematic study of the role of these receptors with the development of a model that could help other investigators.

Specific comments:

The authors have made a good faith effort to respond to the prior reviews, including new experimental data. My comments are minor and are mostly for clarification.

1\. In the Abstract (line 28), the authors should include glycine receptors among the channels examined.

2\. Introduction (line 60). \...input should be inputs.

3\. Page 17. The authors comment about the percent of resting conductance accounted for by GABA receptors. They should do the same for glycine since they make a point of using both GABA and glycine to activate chloride currents in their other analyses.

4\. Line 479. The term "spontaneously" open receptors has different meanings for different physiologists. In some cases this can refer to unliganded receptors. I suggest they delete the word "spontaneously" (this doesn\'t change their meaning and avoids the confusion).

5\. Figure 2 legend, line 888. Panel C does not show voltage ramps.

Reviewer 2.

General comment:

The manuscript "Contribution of Resting Conductance, GABAA-Receptor Mediated Miniature Synaptic Currents and Neurosteroid to Chloride Homeostasis in Central Neurons" by Yelhekar and coworkers investigates the mechanisms regulating the intracellular chloride concentration in neurons. In particular this work aims at understanding the pathways of chloride extrusion after "massive chloride loading", a condition that might approximate sustained and repetitive inhibitory synaptic activity.

By using electrophysiological and pharmacological approaches, the Authors conclude that chloride extrusion does not only occur through the conventional KCC2-mediated pathway, but it is significantly mediated by a chloride ions flux through GABAA receptors (at membrane resting potentials).

This topic is extremely relevant. Indeed, after inhibitory activity, the increase of intracellular chloride relaxes back to baseline in tens (or hundreds) of seconds, a time that is orders of magnitude longer than the synaptic integration times. This implies that the dynamics of chloride extrusion heavily impact on inhibitory short term synaptic plasticity with obvious consequences on the network functioning.

The present study is well conducted technically very sound. The experimental evidence shown, in general, supports the conclusion made by the Authors and increases our knowledge about the mechanisms of chloride homeostasis during inhibitory activity. Indeed, as far as I know, it is currently known that in addition to KCC2, only ClC-2 channels may contribute to "assist" chloride extrusion.

However, there are some points that need to be clarified.

Major points:

Although the Authors convinced me that GABAA receptors in mediating chloride extrusion, the experiments carried out to dissect out the type of GABAA receptors (tonic vs phasic) are not fully conclusive.

1\. While PTX is reported to slow the rate of \[Cl-\] recovery, Gabazine is ineffective. Basing on these experiments the authors conclude that the chloride extrusion is mediated by Gabazine-independent receptors spontaneously open. Similar receptor pharmacology has been described in Wlodarczyk et al., (2013). In this study, however, such "spontaneously open receptors" have been shown not to contain the delta subunit. In the experiment with the positive allosteric modulator DS2, in contrast, the Authors state: "\[Cl-\]i recovery may be pharmacologically enhanced via positive modulation of δ-subunit containing GABAA receptors". How the authors reconcile this discrepancy also in the light that delta-containing GABAA receptors have been extensively shown to be blocked by Gabazine? Which GABAAR subunit composition do the authors believe is mediating such \[Cl-\] recovery process?

2\. It is a bit puzzling to me to understand why the authors used Allopregnanolone to dissect out the contribution of synaptic GABAA receptors (mediating mIPSCs). Indeed, this neurosteroid is mainly known for its effect on delta-containing, tonic, extrasynaptic GABAA receptors. By using this drug, it is difficult to specifically isolate the component mediated by synaptic receptors. Why the authors did not use benzodiazepines (BZDs) instead? BZDs selectively potentiate gamma-containing synaptic receptors (mediating mIPSCS) and have been reported to slow down the decay kinetics of mIPSCs.

3\. If the authors think that receptors openings during synaptic activity (mIPSCs) are involved in the chloride recovery, it would be very elegant to selectively increase mIPSCs frequency by using, for instance, latrotoxin or by playing with the Ca/Mg ratio. In this case the effect of postsynaptic receptor would be unmasked without the need to interfere with the receptors themselves.

4\. It is surprising that the \[Cl-\]i recovery does not change in the presence of TTX, since the frequency of sIPSCs is typically higher than that of mIPSCs. However in some preparations the action potential (AP) driven activity is similar to AP-independent activity. Is that the case of your experimental model (isolated preoptic neurons)? Please comment on this.

Minor points

1\. In the abstract and in several other points it is stated that AP-independent currents (mIPSCs) are important for chloride recovery. Why is it important to specify "impulse-independent release of GABA"? Wouldn\'t the rationale of the study hold true if the current were AP-driven (sIPSCs)? After all, in the brain most of IPSCs are AP driven.

2\. I would change "impulse" with "action potential"

3\. I found a bit distracting the use of sentences between brackets after a period. Example: "\...\...recovery of a low \[Cl-\]i. (In the absence of Cl- transporters, the Cl- equilibrium potential, ECl, will settle at the membrane resting potential.)". I would get rid of brackets and link the sentence to the previous.

4\. I found the discussion a bit verbose
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